Showing results (541-550 of 857) with videos related to

Sort By:
Pageof 86
Plos One|March 27, 2015
Renal primordia activate kidney regenerative events in a rat model of progressive renal diseaseBarbara Imberti, Daniela Corna, Paola Rizzo, et al.
Plos One|July 17, 2024
GFR measurement in patients with CKD: Performance and feasibility of simplified iohexol plasma clearance techniquesFabiola Carrara, Flavio Gaspari, Matias Trillini, et al.
Molecular Immunology|July 23, 2023
Liver factor B silencing to cure C3 glomerulopathy: Evidence from a mouse model of complement dysregulationCristina Zanchi, Monica Locatelli, Daniela Corna, et al.
Nephron|December 23, 2014
Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney diseaseCarlamaria Zoja, Daniela Corna, Monica Locatelli, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2004
Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failureMarina Morigi, Barbara Imberti, Carla Zoja, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 5, 2010
Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the International Society of Nephrology screening programsSanjib Kumar Sharma, Hequn Zou, Ariunaa Togtokh, et al.
Scientific Reports|March 7, 2015
Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injuryBarbara Imberti, Susanna Tomasoni, Osele Ciampi, et al.
Nephron|July 21, 2026
Sustained terminal complement inhibition on the endothelium with ravulizumab in patients with atypical Haemolytic Uremic SyndromeSara Gastoldi, Elena Bresin, Andrea Pasini, et al.
Transplantation|June 28, 2011
Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in ratsPaola Cassis, Nadia Azzollini, Samantha Solini, et al.
American Journal of Physiology. Renal Physiology|August 14, 2009
Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetesElena Gagliardini, Daniela Corna, Carla Zoja, et al.
Pageof 86